Heron Therapeutics, Inc.HRTXNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank79
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-27.59M
↑ 78% vs avg
Percentile
P79
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-126.48M
Historical baseline
PeriodValueYoY Change
2025$-27.59M-22.5%
2024$-22.53M+61.7%
2023$-58.79M+60.0%
2022$-146.91M+27.8%
2021$-203.35M-10.0%
2020$-184.82M-48.4%
2019$-124.58M+35.0%
2018$-191.81M-12.6%
2017$-170.30M-27.0%
2016$-134.10M-